Abstract
Objective
Design
Setting
Participants
Interventions
Main Outcome Measures
Results
Conclusions
Keywords
List of abbreviations:
BBS (Berg Balance Scale), CSS (Clinical Severity Score), FSHD (facioscapulohumeral muscular dystrophy), MMT (manual muscle testing), 6MWT (6-minute walk test), 10MWT (10-meter walk test), TUG (timed Up and Go)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Archives of Physical Medicine and RehabilitationReferences
- Population-based incidence and prevalence of facioscapulohumeral dystrophy.Neurology. 2014; 83: 1056-1059
- Facioscapulohumeral muscular dystrophy.Muscle Nerve. 2006; 34: 1-15
- Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment.Eur J Phys Rehabil Med. 2012; 48: 393-402
- Balance and walking involvement in facioscapulohumeral dystrophy: a pilot study on the effects of custom lower limb orthoses.Eur J Phys Rehabil Med. 2013; 49: 169-178
- Epidemiology and pathophysiology of falls in facioscapulohumeral disease.J Neurol Neurosurg Psychiatry. 2009; 80: 1357-1363
- Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype.Ann Neurol. 1999; 45: 751-757
- Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures.Phys Ther. 1984; 64: 41-45
- Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy.Phys Ther. 1992; 72 (discussion 122-6): 115-122
- Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.Phys Ther. 1994; 74: 253-263
- 171st ENMC international workshop: standards of care and management of facioscapulohumeral muscular dystrophy.Neuromuscul Disord. 2010; 20: 471-475
- Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds.Phys Ther. 2002; 82: 128-137
- Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism.Phys Ther. 2008; 88: 733-746
- Minimal detectable changes of the Berg Balance Scale, Fugl-Meyer Assessment Scale, Timed “Up & Go” Test, gait speeds, and 2-minute walk test in individuals with chronic stroke with different degrees of ankle plantarflexor tone.Arch Phys Med Rehabil. 2012; 93: 1201-1208
- The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.Muscle Nerve. 2010; 41: 500-510
- Performance-oriented assessment of mobility problems in elderly patients.J Am Geriatr Soc. 1986; 34: 119-126
- Motor control theory and applications.Lippincott Williams & Wilkins, Baltimore1995
- [A motor function measurement scale for neuromuscular diseases - description and validation study].Rev Neurol (Paris). 2006; 162 ([French]): 485-493
- Trunk muscle involvement is most critical for the loss of balance control in patients with facioscapulohumeral muscular dystrophy.Clin Biomech (Bristol, Avon). 2014; 29: 855-860
- Gait propulsion in patients with facioscapulohumeral muscular dystrophy and ankle plantarflexor weakness.Gait Posture. 2015; 41: 476-481
- Statistical methods for rates and proportions.John Wiley & Sons, Hoboken2003
- Responsiveness of the motor function measure in neuromuscular diseases.Arch Phys Med Rehabil. 2012; 93: 2251-2256.e1
- The measurement of observer agreement for categorical data.Biometrics. 1977; 33: 159-174
- Relationships between impairment and physical disability as measured by the functional independence measure.Arch Phys Med Rehabil. 1993; 74: 566-573
Article info
Publication history
Footnotes
Supported by the Dutch Facioscapulohumeral Dystrophy Foundation and POM VIGO.
The sponsors had no involvement in study design, data collection, data interpretation, writing, or submission of the manuscript.
Disclosures: All authors received a grant from the Dutch Facioscapulohumeral Dystrophy Foundation and N.H.R., A.C.G., and V.W. received a grant from POM VIGO during the conduct of the study.